TTD | Drug: D02UBC

Drug General Information
Drug ID	D02UBC
Former ID	DIB016901
Drug Name	MEDI6383
Drug Type	Antibody
Indication	Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48]		Phase 1	[549576]
Target and Pathway
Target(s)	OX40 ligand	Target Info		[549704]
KEGG Pathway	Cytokine-cytokine receptor interaction
NetPath Pathway	TGF_beta_Receptor Signaling Pathway
NetPath Pathway	TSLP Signaling Pathway
Reactome	TNFs bind their physiological receptors
WikiPathways	Vitamin D Receptor Pathway
WikiPathways	TSLP Signaling Pathway
References
Ref 549576	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800041453)
Ref 549704	J Clin Oncol 33, 2015 (suppl; abstr 3056).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information